Expert Opinion essays, written by well-known, frequently published experts, discuss interesting topics of research or new advances in the field.
Important terms are defined in the margins of the pages on which they appear, enabling readers to easily check the meaning of an unfamiliar term where it appears in context.
Margin notes highlight important concepts and points, remind readers of previously discussed topics, offer an alternative perspective, or refer readers to other sources for further information.
Material conforms to the most recent AABB standards for the most accurate, up-to-date information on immunohematology.
Advanced concepts, beyond what is required for entry-level practice, are set apart from the rest of the text so readers can easily differentiate between basic and advanced information.
A new chapter on Hematopoietic Stem Cells and Cellular Therapy (chapter 19) provides cutting-edge coverage of cellular therapy and its relevance to blood-banking.
New content has been added on molecular genetics, component therapy, and International Society of Blood Transfusion (ISBT) nomenclature, as well as the latest information on HIV, hepatitis, quality assurance, and information systems.
Coverage of new technologies, such as nucleic acid technology and gel technology, keeps readers current with advances in the field.
Section 1. Basic Science Review 1. Fundamentals of Genetics: Blood Bank Applications 2. Immunology: Review and Applications
Section 2. Blood Group Serology 3. The ABO and H Blood Group Systems 4. The Lewis, Secretor and Soluble ABH Antigens: The I and P Blood Group Systems 5. The Rh Blood Group System 6. Other Blood Group Systems 7. The HLA System
Section 3. Donation, Preparation, and Storage 8. Donor Screening and Phlebotomy 9. Component Preparation 10. Blood Component Preservation and Storage
Section 4. Pretransfusion Testing 11. Compatibility Testing 12. Antibody Identification 13. Resolving ABO Typing Discrepancies and Other Typing Problems
Section 6. Clinical Considerations 16. Hemolytic Disease of the Fetus and Newborn 17. Transfusion Issues in Selected Patient Populations 18. Autoimmune and Drug-Induced Immune Hemolytic Anemias 19. Hematopoietic Stem Cells and Cellular Therapy
Section 7. Safety, Quality Assurance, and Data Management 20. Safety 21. Quality Control, Quality Assurance, Quality Improvement, and Peer Review 22. Record Keeping and Computers
We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors.
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
You may also be able to exercise your privacy choices as described in our Privacy Policy
Manage Consent Preferences
Strictly Necessary Cookies
Always active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.